TOM Kits logo

Emergent Drug Panel Kit (EDP Kit)

The EDP Kit contains reference materials that support laboratory screening for 60 emergent synthetic opioids, benzodiazepines, stimulants, hallucinogens, and synthetic cannabinoids.

These materials are distributed by Cayman Chemical, an ISO-accredited reference material producer, to labs in the US and its territories. Labs eligible to apply for the EDP kit must have a valid DEA controlled substance registration for Schedule I controlled substances.

Traceable Opioid Material® Kits are reference materials and do not eliminate the need to meet analytical method requirements of other federal agencies or the need to comply with state and local regulations. Traceable Opioid Material® Kits are not for diagnostic use.

Compounds in the EDP Kit

Additional Product Information

  • Includes 200 micrograms of each compound
  • Includes the most prevalent compounds identified on DEA Emerging Threat Reports and CFSRE Scope and Trend Reports (2019-2022)
  • Improves immunoassay and mass spectrometry screening methods

Safety Data Sheets, Certificates of Analyses, and Other Product-Specific Documents

Request the EDP Kit

TOM Kits logo, TRACEABLE OPIOID MATERIAL®, and TOM Kits® are registered marks of HHS.